부비동 조직 절제술 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Sinus Tissue Resection Market Growth & Trends:

The global sinus tissue resection market size is expected to reach USD 311.4 million by 2030, registering to grow at a CAGR of 5.08% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing incidence of chronic diseases such as asthma, rhinitis, and allergies and the rising competition among key industry participants are the major factors contributing to the market growth. Companies operating in the industry, such as Integra LifeSciences and Medtronic plc, are acquiring other companies to strengthen their presence in the industry and boost the product portfolio for sinus and ENT surgeries.

The growing incidences of chronic disorders such as rhinitis and Asthma are expected to boost the sinus tissue resection market growth over the forecast period. According to an article published by the WHO in May 2023, approximately 455,000 individuals worldwide died due to Asthma in 2019. In addition, Asthma affected 262 million individuals. Moreover, sinusitis is associated with severe asthma patients. So, having Asthma increases the chances of acquiring a sinus infection. Thus, the rising incidences of Asthma are anticipated to boost the sinus tissue resection market growth in the coming years.

Furthermore, the rising technological advancements and product launches are expected to propel market growth in the coming years. Manufacturers and researchers are developing advanced products to help during sinus surgeries. For instance, according to the study published by Springer Nature Limited in February 2022, a steerable, functional, single-handed endoscope, PliENT, has been developed for maxillary sinus surgery. The performance of the endoscope was inspected in this study. Using this endoscope, an increased field of view can be obtained compared to currently utilized endoscopes. Thus, such novel endoscope developments for sinus and ear nose and throat (ENT) procedures are expected to boost market growth.

Sinus Tissue Resection Market Report Highlights:

• The endoscope sub-segment dominated the product segment, with a revenue share of 35.9% in 2024, owing to the increasing adoption of minimally invasive procedures.
• The nasal scissors product segment is expected to grow at the fastest CAGR from 2025 to 2030, due to the availability of nasal scissors from several industry players, such as Integra LifeSciences Corporation, Surtex Instruments, and Millennium Surgical.
• Based on end-use, the hospital segment dominated the market with a revenue share of 41.80% in 2024, due to the presence of a large number of hospitals conducting various ear nose and throat procedures.
• The clinics end-use segment is expected to register the fastest CAGR in the coming years, owing to advantages such as lower costs associated with clinic facilities.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. End Use
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Global Sinus Tissue Resection Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing preference for minimally invasive surgeries
    • 3.2.1.2. Advancements in technology
    • 3.2.1.3. Growing prevalence of chronic sinusitis
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Shortage of skilled professionals
    • 3.2.2.2. Limited healthcare spending and lack of awareness in emerging economies
• 3.3. Global Sinus Tissue Resection Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Global Sinus Tissue Resection Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Sinus Tissue Resection Market: Product Movement Analysis
• 4.3. Global Sinus Tissue Resection Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Endoscopes
    • 4.4.1.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
  • 4.4.2. Ethmoid Forceps
    • 4.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 4.4.3. Nasal Scissors
    • 4.4.3.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
  • 4.4.4. Curettes
    • 4.4.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)

Chapter 5. Global Sinus Tissue Resection Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Sinus Tissue Resection Market: End Use Movement Analysis
• 5.3. Global Sinus Tissue Resection Market by End Use Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Hospitals
    • 5.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 5.4.2. Ambulatory Surgical Centers
    • 5.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 5.4.3. Clinics
    • 5.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)

Chapter 6. Global Sinus Tissue Resection Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Chapter Global Sinus Tissue Resection Market Movement Analysis
• 6.3. Global Sinus Tissue Resection Market: Regional Estimates & Trend Analysis
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3.6.
  • 6.5.4. Europe
  • 6.5.5. Europe Global Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. UK
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Competitive Scenario
    • 6.5.6.3. Regulatory Framework
    • 6.5.6.4. Reimbursement scenario
    • 6.5.6.5. UK Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Germany
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Reimbursement scenario
    • 6.5.7.5. Germany Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. France
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Competitive Scenario
    • 6.5.8.3. Regulatory Framework
    • 6.5.8.4. Reimbursement scenario
    • 6.5.8.5. France Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Italy
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Competitive Scenario
    • 6.5.9.3. Regulatory Framework
    • 6.5.9.4. Reimbursement scenario
    • 6.5.9.5. Italy Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.10. Spain
    • 6.5.10.1. Key Country Dynamics
    • 6.5.10.2. Competitive Scenario
    • 6.5.10.3. Regulatory Framework
    • 6.5.10.4. Reimbursement scenario
    • 6.5.10.5. Spain Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.11. Denmark
    • 6.5.11.1. Key Country Dynamics
    • 6.5.11.2. Competitive Scenario
    • 6.5.11.3. Regulatory Framework
    • 6.5.11.4. Reimbursement scenario
    • 6.5.11.5. Denmark Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.12. Sweden
    • 6.5.12.1. Key Country Dynamics
    • 6.5.12.2. Competitive Scenario
    • 6.5.12.3. Regulatory Framework
    • 6.5.12.4. Reimbursement scenario
    • 6.5.12.5. Sweden Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.13. Norway
    • 6.5.13.1. Key Country Dynamics
    • 6.5.13.2. Competitive Scenario
    • 6.5.13.3. Regulatory Framework
    • 6.5.13.4. Reimbursement scenario
    • 6.5.13.5. Norway Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. Japan Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. China Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. India Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement scenario
    • 6.6.5.5. South Korea Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Reimbursement scenario
    • 6.6.6.5. Australia Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Reimbursement scenario
    • 6.6.7.5. Thailand Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Brazil Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. Argentina Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.4. Mexico
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. Mexico Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Middle East & Africa
  • 6.8.1. Middle East & Africa Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. South Africa Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. Saudi Arabia Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. Reimbursement scenario
    • 6.8.4.5. UAE Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Reimbursement scenario
    • 6.8.5.5. Kuwait Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Medtronic
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Stryker (Entellus Medical, Inc.)
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. INTEGRA LIFESCIENCES
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. B. Braun Melsungen AG
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Stille
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. KARL STORZ
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. CARDIMED INTERNATIONAL
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. Novo Surgical Inc
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. Surtex Instruments
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. Xelpov Surgical
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives